Abbott India Limited (IN:ABBOTINDIA)

:ABBOTINDIA

ABBOTINDIA

Abbott India Limited

RESEARCH TOOLSreports

Want to see IN:ABBOTINDIA full AI Analyst Report?

Abbott India Limited (ABBOTINDIA) Price & Analysis

1 Followers

ABBOTINDIA Stock Chart & Stats

₹28101.15

₹188.10(0.64%)

At close: Jan 09 4:00 PM EST

₹28101.15

₹188.10(0.64%)

Day’s Range― - ―

52-Week Range₹25,164.00 - ₹35,921.55

Previous CloseN/A

Volume5.43K

Average Volume (3M)628.00

Market Cap

₹591.22B

Enterprise Value₹570.54B

Total Cash (Recent Filing)₹23.42B

Total Debt (Recent Filing)₹1.82B

Price to Earnings (P/E)34.9

Beta0.51

Next Earnings

Aug 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.68%

Share Statistics

EPS (TTM)710.09

Shares Outstanding21,249,302

10 Day Avg. Volume806

30 Day Avg. Volume628

Financial Highlights & Ratios

PEG Ratio3.65

Price to Book (P/B)11.53

Price to Sales (P/S)7.95

P/FCF Ratio33.12

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)810.14

Revenue Forecast (FY)₹75.32B

Bulls Say, Bears Say

Bulls Say

Consistent Revenue ExpansionSteady revenue growth over five years signals durable demand and effective commercial execution across therapy areas. This sustained top-line expansion supports scalable margins, reinvestment capacity, and long-term market share maintenance for branded prescription products.

Extremely Conservative Balance SheetVery low leverage and rising equity provide substantial financial flexibility to fund R&D, M&A or withstand shocks. Strong ROE (~32.5%) alongside minimal debt reduces refinancing risk and preserves strategic optionality over multiple market cycles.

High-quality Cash GenerationFCF near parity with net income indicates excellent cash conversion from operations, enabling sustainable dividends, capex, and internal investment without reliance on external funding. This strengthens long-term capital allocation and resilience.

Bears Say

Sharp Gross Margin DeteriorationA large gross margin decline suggests adverse mix, cost inflation, or pricing pressure that could compress sustainable profitability. If structural, this weakens the firm's ability to maintain elevated operating margins and fund growth without margin recovery or price adjustments.

Volatile Free Cash Flow GrowthWhile absolute FCF is strong, swings in FCF growth introduce uncertainty around the timing of discretionary investments and payouts. Persistent volatility can hinder long-term planning, capital allocation consistency, and confidence in recurring cash generation.

Slowing Revenue Growth Rate In 2026A deceleration in growth may indicate market saturation, intensifying competition, or pricing challenges. Over the medium term, slower top-line momentum constrains margin expansion and reduces the runway for organic growth unless offset by new products or geographic expansion.

ABBOTINDIA FAQ

What was Abbott India Limited’s price range in the past 12 months?

Abbott India Limited lowest stock price was ₹25164.00 and its highest was ₹35921.55 in the past 12 months.

What is Abbott India Limited’s market cap?

Abbott India Limited’s market cap is ₹591.22B.

When is Abbott India Limited’s upcoming earnings report date?

Abbott India Limited’s upcoming earnings report date is Aug 12, 2026 which is in 78 days.

How were Abbott India Limited’s earnings last quarter?

Abbott India Limited released its earnings results on May 11, 2026. The company reported ₹185.8 earnings per share for the quarter, missing the consensus estimate of ₹186.7 by -₹0.9.

Is Abbott India Limited overvalued?

According to Wall Street analysts Abbott India Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Abbott India Limited pay dividends?

Abbott India Limited pays a Annually dividend of ₹475 which represents an annual dividend yield of 1.68%. See more information on Abbott India Limited dividends here

What is Abbott India Limited’s EPS estimate?

Abbott India Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Abbott India Limited have?

Abbott India Limited has 21,249,302 shares outstanding.

What happened to Abbott India Limited’s price movement after its last earnings report?

Abbott India Limited reported an EPS of ₹185.8 in its last earnings report, missing expectations of ₹186.7. Following the earnings report the stock price went up 4.184%.

Which hedge fund is a major shareholder of Abbott India Limited?

Currently, no hedge funds are holding shares in IN:ABBOTINDIA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Abbott India Limited

Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, pre-term labor, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.